92 Participants Needed

Probiotic for Gut Health

MM
JK
Overseen ByJane Kohan

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial examines how the probiotic supplement Bifidobacterium adolescentis iVS-1 can improve gut health and alleviate moderate to severe digestive issues such as bloating, abdominal pain, and gas. Researchers aim to determine if the probiotic can also enhance sleep and reduce anxiety. Participants will be divided into two groups: one receiving the probiotic and the other a placebo (a pill with no active ingredient), without knowing which one they are taking. This trial suits those with ongoing digestive problems who are interested in exploring probiotics for relief. Participants must be willing to use a smartphone app and complete surveys over 17 weeks. As an unphased trial, this study provides a unique opportunity to explore the potential benefits of probiotics for digestive health and overall well-being.

Will I have to stop taking my current medications?

You don't have to stop your current medications, but if you're taking anxiety medications, cannabis, or nicotine products, you need to be on a stable dose for at least 4 weeks before and during the study. You must avoid taking probiotics or prebiotics during the study.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Studies have shown that Bifidobacterium adolescentis iVS-1 is generally safe for humans. Known for its benefits to gut health, this probiotic does not carry antibiotic resistance or harmful genes. Experts consider it safe based on scientific evidence, and it is classified as GRAS (Generally Recognized as Safe).

Research also suggests that this probiotic can aid in better digestion and improved sleep. Its safety record is strong, with no major side effects reported in studies. Participants in past research tolerated the probiotic well, indicating its safety for human use.12345

Why are researchers excited about this trial?

Unlike the standard gut health treatments, which often involve dietary changes and medications, Bifidobacterium adolescentis iVS-1 is a probiotic supplement specifically targeting gut health. This treatment is unique because it introduces a beneficial bacterium directly into the gut, potentially enhancing the balance of gut flora more effectively than traditional methods. Researchers are excited about this probiotic because it offers a natural and potentially more sustainable approach to improving gut health, which could lead to better overall digestive wellness without the side effects associated with some pharmaceuticals.

What evidence suggests that this trial's treatments could be effective for gastrointestinal discomfort?

Research has shown that Bifidobacterium adolescentis iVS-1 can improve gut health. In one study, participants who took this probiotic for two weeks experienced reduced symptoms such as diarrhea and urgency. It also improved lactose digestion. Another study found that it relieved constipation by balancing gut bacteria. Participants taking iVS-1 reported fewer daily symptoms compared to those on a placebo. These findings suggest that iVS-1 may ease stomach and digestive discomfort. In this trial, participants will be randomized to receive either the iVS-1 Probiotic Supplement or a matching placebo to further evaluate its effectiveness.16789

Who Is on the Research Team?

NC

Noah Craft, MD

Principal Investigator

People Science, Inc.

Are You a Good Fit for This Trial?

Adults aged 18-75 with moderate to severe gastrointestinal discomfort, who are interested in their gut health and willing to avoid other probiotics or prebiotics during the study. Participants should have stable medication use if taking anxiety meds, cannabis products, or nicotine.

Inclusion Criteria

* If using any nicotine-containing products, must be on a stable regimen for at least 4 weeks prior to randomization and throughout the course of the study.
* In good general health at the time of screening (Investigator discretion).
* Able to read and understand English.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Randomization and Shipping

Participants are randomized to either the iVS-1 Probiotic Supplement or placebo group, and products are shipped to participants

1 week

Baseline

Baseline assessments are conducted using self-reported outcome questionnaires and at-home stool collection

1 week

Treatment

Participants receive the study product or placebo for 6 weeks, with assessments at baseline and at the end of weeks 2, 4, and 6

6 weeks
Remote assessments via mobile app

Follow-up

Participants are monitored for safety and effectiveness after treatment, including at-home stool collection

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Bifidobacterium adolescentis iVS-1

Trial Overview

The trial is testing a consumer-grade probiotic supplement called B. Adolescentis iVS-1 against a placebo to see its effects on gastrointestinal symptoms and related outcomes like sleep and stress over up to 17 weeks using questionnaires and stool samples.

How Is the Trial Designed?

2

Treatment groups

Active Control

Placebo Group

Group I: ActiveActive Control1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Synbiotic Health

Lead Sponsor

People Science, Inc.

Industry Sponsor

Trials
7
Recruited
730+

Citations

NCT07408518 | Impact of B. Adolescentis iVS-1 Probiotic ...

The study aims to evaluate the probiotic's effects not only on gastrointestinal symptoms but also on secondary outcomes like sleep disturbance, ...

Two-week supplementation of Bifidobacterium ...

Two-week supplementation of Bifidobacterium adolescentis iVS-1 reduces fecal urgency and diarrhea and enhances overall lactose tolerance in lactose ...

Bifidobacterium adolescentis Strengthens Gut Barrier in Post ...

Current evidence demonstrates that Bifidobacterium alleviates functional constipation through modulation of gut microbiota and enhancement of ...

Two-week supplementation of Bifidobacterium ...

The iVS-1 group reported less overall daily symptoms during the treatment period when compared to placebo (p = 0.032) and had significant improvement for fecal ...

Probiotic for Gut Health

The trial is testing a consumer-grade probiotic supplement called B. Adolescentis iVS-1 against a placebo to see its effects on gastrointestinal ...

Experience Healthy Aging with B. adolescentis

iVS-1® excels in GABA production, which can provide a range of health benefits related to cognitive function, pain management, sleep quality and gut health.

Genome analysis of Bifidobacterium adolescentis and ... - PMC

Genome analysis of Bifidobacterium adolescentis and investigation of its effects on inflammation and intestinal barrier function

A Bifido Bacteria to Improve Lactose Digestion and Tolerance

Bifidobacterium adolescentis IVS-1 presents a unique opportunity to evaluate both species and dose of a very well characterized probiotic in ...

Our Probiotic Strains

The probiotics within Ele Chocolates, (Bifidobacterium adolescentis) iVS-1® and (Bifidobacterium longum) iVE-15®, are naturally occurring friendly bacteria.